Ethical Pharma Marketing: Oxymoronic?
The Industry Veteran (a pseudonym) over at The Health Care Blog yesterday wrote a piece that criticized pharmaceutical marketing and concluded that "Pharma has...
Pharma Image Makeover Tactics Unconvincing
Last week, the Wall Street Journal reported that "the pharmaceutical industry is undertaking a makeover of its public image." (See "Stung by Public Distrust,...
Merck Changes Tactics, Lawyers Too
In the wake of last week's verdict in the first Vioxx liability case (see Merck Found Negligent!, Jury as Focus Group, and Merck science...
Are Pharma Ad $ Moving Online?
Tris Hussey over at Rx Market Share Blog sees an upward trend in pharmaceutical marketing and advertising online (see "Pharma looks online for relief")....
Merck science “like wah, wah, wah”
As reported in yesterday's Wall Street Journal ("Merck Loss Jolts Drug Giant, Industry"; 8/22/2005). the jurors in the first Vioxx liability case dismissed the...
Jury as Focus Group
While Merck is pre-occupied planning its appeal of last week's judgment against the company in the first Vioxx liability case, it is hoped that...
Merck Found Negligent!
As reported by the Wall Street Journal: "Merck & Co. was found negligent in the death of a 59-year-old triathlete who used Vioxx, a...
Pharma Marketing Newspeak
Although I am willing to forgive a little bit of pharma marketing BS (see "Is pharmaceutical Marketing BS?"), I am queasy about out-and-out deception,...
Alternative to DTC: cDetailing
Last week I posted what I hoped would be the beginning of a series of ideas about alternatives to DTC (see "Alternatives to DTC,...
Movies and Drugs: Same Blockbuster Mentality
You are probably aware of certain connections between Hollywood and Raritan (the nexus of Pharma's heartland); i.e., between the movie industry and the drug...
